    Maria Hilado | PepsiCo , Inc. | ZoomInfo.com


AGN Maria Teresa Hilado Insider Trades for Allergan PLC


































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Allergan PLC

                  NYSE: AGN
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Allergan PLC



After Hours
 --Quotes are delayed by 20 min
Jul 28, 2017, 5:14 p.m.


AGN

/quotes/zigman/53242416/composite


$
253.01




Change

0.00
0.00%

Volume
Volume 32,763
Quotes are delayed by 20 min








/quotes/zigman/53242416/composite
Previous close

$
			254.16
		


$
				253.01
			
Change

-1.15
-0.45%





Day low
Day high
$251.71
$254.99










52 week low
52 week high

            $184.50
        

            $256.80
        


















Insider Activity


Individual




Maria Teresa Hilado



Ms. Maria T. Hilado is Chief Financial Officer at Allergan Plc, Independent Director at H.B. Fuller Co., and Co-Chairman-Strong Kids Campaign at YMCA of Greater New York. She is on the Board of Directors at KYTHERA Biopharmaceuticals, Inc., Allergan, Inc., and H.B. Fuller Co.
Ms. Hilado was previously employed as Senior Vice President-Finance & Treasury by PepsiCo, Inc., Treasurer & Vice President by Schering-Plough Corp., an Assistant Treasurer by General Motors Corp., Chief Financial Officer by GMAC Commercial Finance LLC, and Chief Financial Officer by General Motors Acceptance Corp. She also served on the board at Bausch & Lomb, Inc.
She received her undergraduate degree from the University of Ateneo de Manila and an MBA from the University of Virginia Darden School of Business.



Transactions


Date
Shares
Transaction
Value





04/03/2017
6,311


 
Award at $237.68 per share.


1,499,998


11/11/2016
720


 
Acquisition at $208.05 per share.


149,796


11/11/2016
702


 
Acquisition at $213.31 per share.


149,743


06/02/2016
661


 
Acquisition at $241.57 per share.


159,677


12/08/2014
11,296


 
Award at $265.57 per share.


2,999,878





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Brenton L. Saunders 
Chairman, President & Chief Executive Officer




Mr. Robert A. Stewart 
Chief Operating Officer




Ms. Maria Teresa Hilado 
Chief Financial Officer




Dr. C. David Nicholson 
Chief Research & Development Officer




Mr. William J. Meury 
Chief Commercial Officer




Mr. Jonathon  Kellerman 
Global Chief Compliance Officer & Executive VP




Dr. Hafrun  Fridriksdottir 
SVP-Generics Research & Development




Mr. Paul  Navarre 
Executive VP & President-International Brands




Dr. Philippe A. Schaison 
Executive Vice President




Mr. Joseph H. Boccuzi 
Director




Mr. Paul M. Bisaro 
Director




Mr. James C. Darecca 
Chief Accounting Officer




Ms. Daphne  Karydas 
SVP- Investor Relations & Strategy




Ms. Karina  Calzadilla 
Investor Relations Contact




Mr. Mark  Marmur 
Head-Global Corporate Media Relations




Mr. John Alexander Kelly 
Chief Communications Officer




Ms. Karen L. Ling 
Chief Human Resources Officer




Mr. Ambrose Robert Douglas Bailey 
Secretary & Chief Legal Officer




Dr. Adriane M. Brown 
Independent Director




Dr. Peter John McDonnell 
Independent Director




Dr. Nesli  Basgoz 
Independent Director




Mr. Fred G. Weiss 
Independent Director




Ms. Catherine M. Klema 
Independent Director




Mr. Christopher W. Bodine 
Independent Director




Mr. Christopher J. Coughlin 
Lead Independent Director




Mr. Ronald R. Taylor 
Independent Director




Mr. Patrick J. O’Sullivan 
Independent Director




Mr. James H. Bloem 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




12:01 AM EDT
July 29, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
9:16pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
7:39pBarron's Buzz: Robo 2.0, Facebook and Twitter, Trading On News
7:29pA Wild Week in Washington 
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































FUL Maria Teresa Hilado Insider Trades for H.B. Fuller Co.


































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































H.B. Fuller Co.

                  NYSE: FUL
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

H.B. Fuller Co.



After Hours
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:29 p.m.


FUL

/quotes/zigman/227089/composite


$
51.62




Change

0.00
0.00%

Volume
Volume 5,312
Quotes are delayed by 20 min








/quotes/zigman/227089/composite
Previous close

$
			51.53
		


$
				51.62
			
Change

+0.09
+0.17%





Day low
Day high
$51.15
$51.66










52 week low
52 week high

            $41.52
        

            $54.32
        


















Insider Activity


Individual




Maria Teresa Hilado



Ms. Maria T. Hilado is Chief Financial Officer & Executive Vice President at Allergan Plc, Independent Director at H.B. Fuller Co., and Co-Chairman-Strong Kids Campaign at YMCA of Greater New York. She is on the Board of Directors at KYTHERA Biopharmaceuticals, Inc., Allergan, Inc., and H.B. Fuller Co.
Ms. Hilado was previously employed as Senior Vice President-Finance & Treasury by PepsiCo, Inc., Treasurer & Vice President by Schering-Plough Corp., an Assistant Treasurer by General Motors Corp., Chief Financial Officer by GMAC Commercial Finance LLC, and Chief Financial Officer by General Motors Acceptance Corp. She also served on the board at Bausch & Lomb, Inc.
She received her undergraduate degree from the University of Ateneo de Manila and an MBA from the University of Virginia Darden School of Business.



Transactions


Date
Shares
Transaction
Value





10/03/2013
1,300


 
Award at $0 per share.


0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. James J. Owens 
President, Chief Executive Officer & Director




Ms. Elin E. Gabriel 
Vice President-Global Operations




Mr. John J. Corkrean 
Chief Financial Officer & Executive Vice President




Dr. Ebrahim  Rezai 
Chief Technology & Innovation Officer, VP




Mr. Zhiwei  Cai 
Senior Vice President-Engineering Adhesives




Mr. Heather  Campe 
Senior Vice President-Americas Adhesives




Ms. Traci L. Jensen 
Senior Vice President-Global Construction Product




Mr. Patrick M Kivits 
Senior Vice President-EIMEA




Mr. Steven  Kenny 
Senior Vice President-Emerging Markets




Ms. Heidi  Weiler 
Treasurer & Vice President




Mr. Robert J. Martsching 
Vice President & Controller




Mr. Maximillian  Marcy 
Director-IR & International Finance




Ms. Kimberlee  Sinclair 
Director-Global Communication




Ms. Paula M. Cooney 
Vice President-Human Resources




Mr. Timothy J. Keenan 
Secretary, Vice President & General Counsel




Mr. Lee R. Mitau 
Non-Executive Chairman




Mr. Dante C. Parrini 
Independent Director




Ms. Maria Teresa Hilado 
Independent Director




Mr. R. William van Sant 
Independent Director




Mr. J. Michael Losh 
Independent Director




Mr. John C. van Roden 
Independent Director




Mr. Thomas W. Handley 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




12:01 AM EDT
July 29, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
9:16pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
7:39pBarron's Buzz: Robo 2.0, Facebook and Twitter, Trading On News
7:29pA Wild Week in Washington 
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15





























































	Our Company





























































Text size
A-
A+














Contact Lenses
Contact Lens Care
Dry Eye Products
Allergy/Redness Relief
Rx Pharmaceutical
Eye Wash
Eye Vitamins
Surgical Products
Vision Accessories
Safety and Industrial Cleaning Products
Diagnostics






Lenses for Nearsighted/Farsighted
Bausch + Lomb ULTRA contact lenses
Biotrue ONEday Contact Lenses
PureVision2 Contact Lenses
PureVision Contact Lenses
SofLens daily disposable Contact Lenses
SofLens 38 Contact Lenses
Optima 38/SP Contact Lenses


Lenses for Astigmatism
Bausch + Lomb ULTRA for Astigmatism
Biotrue ONEday for Astigmatism
Soflens Daily Disposable Toric for Astigmatism Contact Lenses
PureVision2 for Astigmatism Contact Lenses
PureVision Toric Contact Lenses
SofLens Toric Contact Lenses
Optima Toric Contact Lenses


Lenses for Presbyopia
Bausch + Lomb ULTRA for Presbyopia
Biotrue ONEday for Presbyopia
PureVision2 for Presbyopia
PureVision Multi-Focal Contact Lenses
SofLens Multi-Focal Contact Lenses
Boston Multivision GP Contact Lenses


Lenses for Cataract Patients
Silsoft and Silsoft Super Contact Lenses


Vision Shaping Treatment
Rebate Center
Rewards Program




Soft Lens Multi-Purpose Solutions
Biotrue multi-purpose solution
renu Advanced Formula
PeroxiClear 3% Hydrogen Peroxide Cleaning & Disinfecting Solution
renu fresh multi-purpose solution
renu sensitive multi-purpose solution


Soft Contact Lens Drops
ReNu MultiPlus Lubricating and Rewetting Drops
ReNu Rewetting Drops
Sensitive Eyes Drops


Other Soft Lens Care Products
Sensitive Eyes Plus Saline
Sensitive Eyes Daily Cleaner


Gas Permeable Contact Lens Solutions
Boston Advance Conditioning Solution and Boston Advance Cleaner
Boston Simplus Multi-Action Solution
Boston Original Conditioning Solution and Cleaner
Peroxiclear Cleaning & Disinfecting Solution
Boston One Step Liquid Enzymatic
Boston Rewetting Drops for GP lenses
Boston Gas Permeable Lens Case


Specialty Lens Care Products
ScleralFil preservative free saline






Dry Eye Products
Soothe XP-Xtra Protection Emollient (Lubricant) Eye Drops
Soothe Long Lasting Hydration Lubricant Eye Drops
Soothe Hydration Lubricant Eye Drops
Soothe Preservative Free Lubricant Eye Drops
Soothe Night Time Ointment
THERA°PEARL Eye Mask
Advanced Eye Relief Dry Eye


Corneal Edema
Muro 128 Solution
Muro 128 Ointment






Alaway Antihistamine Eye Drops
Opcon-A Itching and Redness Reliever Eye Drops
Advanced Eye Relief Maximum Redness
Advanced Eye Relief Redness




Alrex (loteprednol etabonate ophthalmic suspension) 0.2%
BEPREVE (bepotastine besilate ophthalmic solution) 1.5%
Besivance (besifloxacin ophthalmic suspension) 0.6%
LACRISERT (hydroxypropyl cellulose ophthalmic insert)
Lotemax (loteprednol etabonate ophthalmic suspension 0.5%)
Lotemax (loteprednol etabonate ophthalmic-gel) 0.5%
Lotemax (loteprednol etabonate ophthalmic ointment) 0.5%
Istalol (timolol maleate ophthalmic solution) 0.5%
Macugen
PROLENSA (bromfenac ophthalmic solution)
Retisert (fluocinolone acetonide intravitreal implant)0.59 mg
TIMOPTIC 0.25% AND 0.5% (TIMOLOL MALEATE OPHTHALMIC SOLUTION) in OCUDOSE
Visudyne (verteporfin for injection) 15mg
Zirgan
Zylet Ophthalmic Suspension




Advanced Eye Relief Eye Wash
Collyrium for Fresh Eyes Eye Wash




Age Related Eye Vitamins
PreserVision Eye Vitamin AREDS 2
PreserVision Eye Vitamin AREDS Formula Soft Gels
PreserVision Lutein Formula Soft Gel
PreserVision AREDS Forumla Tablets
PreserVision AREDS 2 Formula + Multivitamin


Vitamins for Eye Health
Ocuvite Adult 50+ Formula
Ocuvite Lutein & Zeaxanthin Eye Vitamin
Ocuvite Lutein Eye Vitamin






Cataract Surgery
enVista IOL
Crystalens AO Lens
Trulign Toric IOL
Akreos AO Lens
SofPort Advanced Optics (AO) Aspheric Lens






Consumer Magnifiers
Magnifiers with ErgoTouch Grip
Bar Magnifiers
Illuminated Magnifiers
Illuminated Coddington


Professional Magnifiers
Coddington Magnifiers
Hastings Triplet Magnifiers
Classic Metal Eyeglass Loupes
Watchmaker's Loupes
Hastings Triplet Measuring Magnifiers
Lenscope Magnifiers
Magna-Visor
Folding Pocket Magnifiers
Double Lens Magnifier


Eyewear Accessories
Eyewear Accessories


Eyewear Cleaning Products
Eyewear Cleaning Products


Electronic Device Cleaning Products
Clens Travel Cleaning Kit
Home & Office Cleaning Kit






Disposable Lens Cleaning Stations
FogShield XP Lens Cleaning Station
Large Disposable Lens Cleaning Station
Plastic Disposable Lens Cleaning Station


Permanent Lens Cleaning Stations
Pre-Packed Metal Lens Cleaning Station


Liquid Cleaning Fluids
Liquid Cleaning Fluids


Tissue & Cloth Refills
Tissue & Cloth Refills


Pre Moistened Cleaning Tissues
FogShield XP® Pre-Moistened Lens Cleaning Tissues
Pre-Moistened Tissues
Pre-Moistened Tissues with Silicone
Pre-Moistened Respirator and Equipment Wipes
Peel and Reseal Pre-Moistened Lens Cleaning Tissues






Ocular Allergy Diagnostic System
Sjö Diagnostic Test














Infant Eyes
Child Eyes
Teenager Eyes
20s and 30s eyes
40s and 50s Eyes
60+ Eyes






Eye Development
Eye Exams
Eye Concerns
Eye Safety




Eye Development
Eye Exams
Eye Concerns
Eye Safety




Eye Exams
Maintaining Healthy Eyes
Eye Safety
Vision Correction
Teens and Contact Lenses
Parents Guide to Contact Lenses


Sports and Vision




Eye Exams
Healthy Eyes
Eye Safety
Vision Correction
Sports Vision




Eye Development
Eye Exams
Eye Concerns
Maintaining Healthy Eyes
Vision Correction




Eye Exams
Eye Concerns
Maintaining Healthy Eyes
Vision Correction














Vision Correction
Eye Infections & Irritations
Diseases and Disorders
Eye Injuries
Chronic Conditions
Wearing Contact Lenses






Nearsightedness (Myopia)
Farsightedness (Hyperopia)
Astigmatism
Presbyopia




Allergies
Computer Vision Syndrome (CVS)
Contact Lens Discomfort
Dry Eye
Eyelid Irritation
Pink Eye (conjunctivitis)
Foreign Objects / Eye Irritants
Infected Tear Duct
Sties
Watery Eyes
Tired Eyes




Age-Related Macular Degeneration
Bulging Eyes
Cataracts
Cataracts in Babies
Diabetic Macular Edema
CMV Retinitis
Color Blindness
Crossed Eyes (Strabismus)
Keratoconus
Eye Floaters and Eye Flashes
Glaucoma
Lazy Eye
Ocular Hypertension
Retinal Detachment
Low Vision
Eyelid Twitching
Uveitis




Chemical Eye Burns
Eye Trauma
Foreign Objects / Eye Irritants




Bell's Palsy
Diabetes
Graves’ Disease
Rheumatoid Arthritis
Sjogren’s Syndrome




Teens and Contact Lenses
Wearing and Caring for Contact Lenses














About Bausch + Lomb
Business Integrity
Compliance
Newsroom
Careers
Community Relationships
Grants and Charitable Contributions
Investor Relations
Supplier Diversity
Contract Manufacturing
Worldwide Locations
Contact Us
Formerly Owned Businesses






The Bausch + Lomb Story
Archive Request Form




Code of Business Conduct and Ethics
Corporate Governance Documents
Consumer Product Safety Improvement Act (CPSIA) Certificates


AdvaMed and PhRMA
Verified-Accredited Wholesale Distributor (VAWD)
California Transparency in Supply Chains Act of 2010




2016 Archive
2015 Archive
2014 archive
2013 archive
2012 archive
2011 archive
2010 archive
2009 archive
2008 archive
Media Contacts




Benefits
Retiree Benefits
Employee Benefits
Sustainability and Global Citizenship
Culture
Diversity
Internships




Social Investing
Environmental Sustainability
Science Award and Scholarships
FIRST - For Inspiration and Recognition of Science and Technology
Transfer of Flags Ceremony




Grants and Charitable Contributions Landing
Information and Requirements




Supplier Expectations
Diverse Certification Requirements
Commodities We Purchase
Second Tier Relationships
Diverse Supplier Profile
Contact Us




Contract Manufacturing
About Contract Manufacturing
Capabilities
Products
Contact Us for Contract Manufacturing Opportunities













Search





















Search









Our Company




 


Our Company















 


Bausch + Lomb, a division of Valeant Pharmaceuticals International, Inc., has one of the best-known and most respected healthcare brands in the world.

Offering the world’s most comprehensive portfolio of eye health products, the company’s core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals.

The company began in 1853 in Rochester, New York, and our history of innovation continues today as we invent new materials, engineer new technologies, and create pioneering ways to help people see better to live better.


  About Bausch + Lomb  
 


  Business Integrity  
 


  Newsroom  
 


  Careers  
 


  People Strategy  
 


  Community Relations  
 


  Grants and Charitable Contributions  
 


  Investor Relations  
 


  Supplier Diversity  
 


  Contract Manufacturing  
 


  Bausch + Lomb Technology and Innovation Showcase  
 


  Worldwide Locations  
 


  Contact Us  
 


   
 
























UNITED STATES





--Please Select--
Argentina
Australia
Österreich
Belgique
Brasil

Canada (English)
Canada (Français)
中国
Česká republika
Danmark
Eesti
Suomi
France
Deutschland
Greece
香港

India
Indonesia
Ireland
Italia
日本
한국
Latvia
Lietuva
Malaysia
México
Netherlands
New Zealand
Norge
Pakistan
Philippines
Polska
România
Россия
Singapore

South Africa
España
Sverige
Suisse
Schweiz
Taiwan
Türkiye

United Kingdom
United States





Vision and Eye Health

Vision and Age
Eye Infections & Irritations
Diseases and Disorders
Find a Doctor

Eye Exam Check List





Products

Contact Lenses
Contact Lens Care
Dry Eye Products
Allergy/Redness Relief
Rx Pharmaceutical
Eye Vitamins
Surgical Products
Vision Accessories





Customer Support

Contact Us
Customer policies and forms
Rebate Center
Worldwide Locations





Legal

Legal Notice
Privacy Policy
Safety Data Sheets (SDS)






Newsroom
Careers
Investor Relations
Grants & Contributions





© 2017 Bausch & Lomb Incorporated.
All information and materials on this site pertain to the U.S. only, unless otherwise indicated.









































	Newsroom


































































Text size
A-
A+














Contact Lenses
Contact Lens Care
Dry Eye Products
Allergy/Redness Relief
Rx Pharmaceutical
Eye Wash
Eye Vitamins
Surgical Products
Vision Accessories
Safety and Industrial Cleaning Products
Diagnostics






Lenses for Nearsighted/Farsighted
Bausch + Lomb ULTRA contact lenses
Biotrue ONEday Contact Lenses
PureVision2 Contact Lenses
PureVision Contact Lenses
SofLens daily disposable Contact Lenses
SofLens 38 Contact Lenses
Optima 38/SP Contact Lenses


Lenses for Astigmatism
Bausch + Lomb ULTRA for Astigmatism
Biotrue ONEday for Astigmatism
Soflens Daily Disposable Toric for Astigmatism Contact Lenses
PureVision2 for Astigmatism Contact Lenses
PureVision Toric Contact Lenses
SofLens Toric Contact Lenses
Optima Toric Contact Lenses


Lenses for Presbyopia
Bausch + Lomb ULTRA for Presbyopia
Biotrue ONEday for Presbyopia
PureVision2 for Presbyopia
PureVision Multi-Focal Contact Lenses
SofLens Multi-Focal Contact Lenses
Boston Multivision GP Contact Lenses


Lenses for Cataract Patients
Silsoft and Silsoft Super Contact Lenses


Vision Shaping Treatment
Rebate Center
Rewards Program




Soft Lens Multi-Purpose Solutions
Biotrue multi-purpose solution
renu Advanced Formula
PeroxiClear 3% Hydrogen Peroxide Cleaning & Disinfecting Solution
renu fresh multi-purpose solution
renu sensitive multi-purpose solution


Soft Contact Lens Drops
ReNu MultiPlus Lubricating and Rewetting Drops
ReNu Rewetting Drops
Sensitive Eyes Drops


Other Soft Lens Care Products
Sensitive Eyes Plus Saline
Sensitive Eyes Daily Cleaner


Gas Permeable Contact Lens Solutions
Boston Advance Conditioning Solution and Boston Advance Cleaner
Boston Simplus Multi-Action Solution
Boston Original Conditioning Solution and Cleaner
Peroxiclear Cleaning & Disinfecting Solution
Boston One Step Liquid Enzymatic
Boston Rewetting Drops for GP lenses
Boston Gas Permeable Lens Case


Specialty Lens Care Products
ScleralFil preservative free saline






Dry Eye Products
Soothe XP-Xtra Protection Emollient (Lubricant) Eye Drops
Soothe Long Lasting Hydration Lubricant Eye Drops
Soothe Hydration Lubricant Eye Drops
Soothe Preservative Free Lubricant Eye Drops
Soothe Night Time Ointment
THERA°PEARL Eye Mask
Advanced Eye Relief Dry Eye


Corneal Edema
Muro 128 Solution
Muro 128 Ointment






Alaway Antihistamine Eye Drops
Opcon-A Itching and Redness Reliever Eye Drops
Advanced Eye Relief Maximum Redness
Advanced Eye Relief Redness




Alrex (loteprednol etabonate ophthalmic suspension) 0.2%
BEPREVE (bepotastine besilate ophthalmic solution) 1.5%
Besivance (besifloxacin ophthalmic suspension) 0.6%
LACRISERT (hydroxypropyl cellulose ophthalmic insert)
Lotemax (loteprednol etabonate ophthalmic suspension 0.5%)
Lotemax (loteprednol etabonate ophthalmic-gel) 0.5%
Lotemax (loteprednol etabonate ophthalmic ointment) 0.5%
Istalol (timolol maleate ophthalmic solution) 0.5%
Macugen
PROLENSA (bromfenac ophthalmic solution)
Retisert (fluocinolone acetonide intravitreal implant)0.59 mg
TIMOPTIC 0.25% AND 0.5% (TIMOLOL MALEATE OPHTHALMIC SOLUTION) in OCUDOSE
Visudyne (verteporfin for injection) 15mg
Zirgan
Zylet Ophthalmic Suspension




Advanced Eye Relief Eye Wash
Collyrium for Fresh Eyes Eye Wash




Age Related Eye Vitamins
PreserVision Eye Vitamin AREDS 2
PreserVision Eye Vitamin AREDS Formula Soft Gels
PreserVision Lutein Formula Soft Gel
PreserVision AREDS Forumla Tablets
PreserVision AREDS 2 Formula + Multivitamin


Vitamins for Eye Health
Ocuvite Adult 50+ Formula
Ocuvite Lutein & Zeaxanthin Eye Vitamin
Ocuvite Lutein Eye Vitamin






Cataract Surgery
enVista IOL
Crystalens AO Lens
Trulign Toric IOL
Akreos AO Lens
SofPort Advanced Optics (AO) Aspheric Lens






Consumer Magnifiers
Magnifiers with ErgoTouch Grip
Bar Magnifiers
Illuminated Magnifiers
Illuminated Coddington


Professional Magnifiers
Coddington Magnifiers
Hastings Triplet Magnifiers
Classic Metal Eyeglass Loupes
Watchmaker's Loupes
Hastings Triplet Measuring Magnifiers
Lenscope Magnifiers
Magna-Visor
Folding Pocket Magnifiers
Double Lens Magnifier


Eyewear Accessories
Eyewear Accessories


Eyewear Cleaning Products
Eyewear Cleaning Products


Electronic Device Cleaning Products
Clens Travel Cleaning Kit
Home & Office Cleaning Kit






Disposable Lens Cleaning Stations
FogShield XP Lens Cleaning Station
Large Disposable Lens Cleaning Station
Plastic Disposable Lens Cleaning Station


Permanent Lens Cleaning Stations
Pre-Packed Metal Lens Cleaning Station


Liquid Cleaning Fluids
Liquid Cleaning Fluids


Tissue & Cloth Refills
Tissue & Cloth Refills


Pre Moistened Cleaning Tissues
FogShield XP® Pre-Moistened Lens Cleaning Tissues
Pre-Moistened Tissues
Pre-Moistened Tissues with Silicone
Pre-Moistened Respirator and Equipment Wipes
Peel and Reseal Pre-Moistened Lens Cleaning Tissues






Ocular Allergy Diagnostic System
Sjö Diagnostic Test














Infant Eyes
Child Eyes
Teenager Eyes
20s and 30s eyes
40s and 50s Eyes
60+ Eyes






Eye Development
Eye Exams
Eye Concerns
Eye Safety




Eye Development
Eye Exams
Eye Concerns
Eye Safety




Eye Exams
Maintaining Healthy Eyes
Eye Safety
Vision Correction
Teens and Contact Lenses
Parents Guide to Contact Lenses


Sports and Vision




Eye Exams
Healthy Eyes
Eye Safety
Vision Correction
Sports Vision




Eye Development
Eye Exams
Eye Concerns
Maintaining Healthy Eyes
Vision Correction




Eye Exams
Eye Concerns
Maintaining Healthy Eyes
Vision Correction














Vision Correction
Eye Infections & Irritations
Diseases and Disorders
Eye Injuries
Chronic Conditions
Wearing Contact Lenses






Nearsightedness (Myopia)
Farsightedness (Hyperopia)
Astigmatism
Presbyopia




Allergies
Computer Vision Syndrome (CVS)
Contact Lens Discomfort
Dry Eye
Eyelid Irritation
Pink Eye (conjunctivitis)
Foreign Objects / Eye Irritants
Infected Tear Duct
Sties
Watery Eyes
Tired Eyes




Age-Related Macular Degeneration
Bulging Eyes
Cataracts
Cataracts in Babies
Diabetic Macular Edema
CMV Retinitis
Color Blindness
Crossed Eyes (Strabismus)
Keratoconus
Eye Floaters and Eye Flashes
Glaucoma
Lazy Eye
Ocular Hypertension
Retinal Detachment
Low Vision
Eyelid Twitching
Uveitis




Chemical Eye Burns
Eye Trauma
Foreign Objects / Eye Irritants




Bell's Palsy
Diabetes
Graves’ Disease
Rheumatoid Arthritis
Sjogren’s Syndrome




Teens and Contact Lenses
Wearing and Caring for Contact Lenses














About Bausch + Lomb
Business Integrity
Compliance
Newsroom
Careers
Community Relationships
Grants and Charitable Contributions
Investor Relations
Supplier Diversity
Contract Manufacturing
Worldwide Locations
Contact Us
Formerly Owned Businesses






The Bausch + Lomb Story
Archive Request Form




Code of Business Conduct and Ethics
Corporate Governance Documents
Consumer Product Safety Improvement Act (CPSIA) Certificates


AdvaMed and PhRMA
Verified-Accredited Wholesale Distributor (VAWD)
California Transparency in Supply Chains Act of 2010




2016 Archive
2015 Archive
2014 archive
2013 archive
2012 archive
2011 archive
2010 archive
2009 archive
2008 archive
Media Contacts




Benefits
Retiree Benefits
Employee Benefits
Sustainability and Global Citizenship
Culture
Diversity
Internships




Social Investing
Environmental Sustainability
Science Award and Scholarships
FIRST - For Inspiration and Recognition of Science and Technology
Transfer of Flags Ceremony




Grants and Charitable Contributions Landing
Information and Requirements




Supplier Expectations
Diverse Certification Requirements
Commodities We Purchase
Second Tier Relationships
Diverse Supplier Profile
Contact Us




Contract Manufacturing
About Contract Manufacturing
Capabilities
Products
Contact Us for Contract Manufacturing Opportunities













Search























Search








Our Company  Newsroom






 



Newsroom















 



Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.






















7/17/2017, Monday



Bausch + Lomb Launches Innovative Contact Lens Patient Savings & Rewards Program














7/12/2017, Wednesday



Bausch + Lomb Launches FortifEYE™ Capsular Tension Ring Preloaded Single-use Injector Simplifies CTR Implantation














6/20/2017, Tuesday



Bausch + Lomb Unveils AMD Virtual Experience with State-of-the-Art Technology at Optometry’s Meeting














5/22/2017, Monday



Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution














5/10/2017, Wednesday



Bausch + Lomb Reports Updated Results of the Antibiotic Resistance Monitoring in Ocular MicRoorganisms (ARMOR) Study














5/3/2017, Wednesday



Bausch + Lomb Invites Surgeons to “Test Drive” New Next-Generation Phacoemulsification Platform at the American Society of Cataract and Refractive Surgery in Los Angeles














4/26/2017, Wednesday



Bausch + Lomb Receives 510(k) Clearance from FDA for Vitesse™, the Only Hypersonic, Open Port Vitrectomy System














4/17/2017, Monday



Bausch + Lomb ONE by ONE Recycling Program Reports Over 180,000 Units of Contact Lenses and Blister Packs Saved from Landfills Since Program Launch














4/6/2017, Thursday



Bausch + Lomb Receives 510(k) Clearance from FDA for Stellaris Elite™ Next-Generation Phacoemulsification Platform














3/30/2017



Introducing Bausch + Lomb ULTRA® for Astigmatism Contact Lenses














3/30/2017, Thursday



Bausch + Lomb Announces U.S. Management Team Leadership














3/1/2017, Wednesday



Bausch + Lomb Educates Over 200 Eye Care Professionals During B+Lieve™ Symposium in San Francisco, CA














3/1/2017, Wednesday



Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses














2/1/2017, Wednesday



Bausch + Lomb and Prevent Blindness® Urge Americans to Fight for Their Sight














1/26/2017, Thursday



Bausch + Lomb Specialty Vision Products Introduces ScleralFil™ Solution for Scleral Lens Insertion














1/18/2017, Wednesday



Bausch + Lomb Introduces Zen™ RC Scleral Contact Lenses














1/17/2017, Tuesday



Bausch + Lomb Successfully Defends Patent Covering PreserVision® Eye Vitamins in Case vs. Vitamin Health, Inc.














1/10/2017, Tuesday



Bausch + Lomb ULTRA® for Presbyopia Contact Lenses Parameters Expanded














12/21/2016, Wednesday



Bausch + Lomb Raises $40K+ for Optometry Giving Sight in Support of 2016 World Sight Day Challenge














12/12/2016, Monday



Bausch + Lomb Specialty Vision Products Launches New 28 Lens Zenlens™ Dx Set










Page 1 of 5First   Previous   [1]  2  3  4  5  Next   Last   













 News - Related Links 



Media Contacts
2017 Archives (18)
2016 Archives (30)
2015 Archives (25)
2014 Archives (24)
2013 Archives (36)
2012 Archives (29)
2011 Archives (39)
2010 Archives (67)
2009 Archives (56)
2008 Archives (32)
2007 Archives (44)























UNITED STATES





--Please Select--
Argentina
Australia
Österreich
Belgique
Brasil

Canada (English)
Canada (Français)
中国
Česká republika
Danmark
Eesti
Suomi
France
Deutschland
Greece
香港

India
Indonesia
Ireland
Italia
日本
한국
Latvia
Lietuva
Malaysia
México
Netherlands
New Zealand
Norge
Pakistan
Philippines
Polska
România
Россия
Singapore

South Africa
España
Sverige
Suisse
Schweiz
Taiwan
Türkiye

United Kingdom
United States





Vision and Eye Health

Vision and Age
Eye Infections & Irritations
Diseases and Disorders
Find a Doctor

Eye Exam Check List





Products

Contact Lenses
Contact Lens Care
Dry Eye Products
Allergy/Redness Relief
Rx Pharmaceutical
Eye Vitamins
Surgical Products
Vision Accessories





Customer Support

Contact Us
Customer policies and forms
Rebate Center
Worldwide Locations





Legal

Legal Notice
Privacy Policy
Safety Data Sheets (SDS)






Newsroom
Careers
Investor Relations
Grants & Contributions





© 2017 Bausch & Lomb Incorporated.
All information and materials on this site pertain to the U.S. only, unless otherwise indicated.

















































 



 María Teresa Hilado se incorpora al directorio de Bausch + Lomb 

          










    









 






 











 









María Teresa Hilado se incorpora al directorio de Bausch + Lomb

May 15, 2013, 08:00 ET
		  		  										
						 from   Bausch + Lomb 


		  Latin America  - español
	 


  Brazil  - Português
 English













 
















































 

 















































 

 

 
 
 
 







Bausch + Lomb is a leading global eye health company that is solely focused on protecting, enhancing, and restoring people's eyesight.  Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ...    
 Facebook
 Twitter
 Pinterest

































 




 




Bausch + Lomb is a leading global eye health company that is solely focused on protecting, enhancing, and restoring people's eyesight.  Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments.  We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries.  Founded in 1853, our company is headquartered in Rochester, NY, and employs more than 11,000 people worldwide.  (PRNewsFoto/Bausch + Lomb)
 


 

 




 





 


ROCHESTER, Nueva York, 15 de mayo de 2013 /PRNewswire/ -- Bausch + Lomb, la compañía global de salud ocular, anunció hoy que María Teresa (Tessa) Hilado fue elegida como miembro de su directorio.
(Logo: http://photos.prnewswire.com/prnh/20121221/MM34011LOGO )
La señora Hilado actualmente es vicepresidenta de finanzas y tesorera de PepsiCo, la compañía de alimentos y bebidas con ingresos netos que superan los $65.000 millones.  En su cargo, la señora Hilado tiene la responsabilidad operacional global de la organización de tesorería, que incluye mercados de capital, manejo de efectivo, tesoro internacional, inversiones de pensión y seguros, así como la supervisión del equipo de finanzas para adquisición global de la compañía.  También es miembro de los Comités de Gasto de Capital y Gestión de Riesgos de Productos Básicos de PepsiCo, y preside su Comité de Inversión de Pensiones.  La señora Hilado también pertenece al directorio de Pepsi Bottling Ventures, una empresa de riesgo compartido entre PepsiCo y Suntory.
"Tessa Hilado es una líder de finanzas brillante con vasta experiencia en grandes empresas de productos de consumo y cuidado de la salud globales", manifestó Fred Hassan, presidente del directorio de Bausch + Lomb. "Bausch + Lomb, sus clientes y accionistas serán beneficiados con la experiencia de Tessa en la industria, en finanzas y tesorería".
La señora Hilado cuenta con más de 22 años de experiencia en finanzas, tesorería y estrategia en grandes corporaciones públicas globales a través de diversas industrias. Antes de unirse a PepsiCo el 2009, Hilado fue vicepresidenta y tesorera en Schering-Plough Corporation en el período 2008 – 2009 donde tuvo la responsabilidad operacional global por la organización de tesorería de la compañía y prestó servicio en el Comité de Inversión de Pensiones.  Previo a eso, Hilado pasó 17 años en General Motors (GM) Corporation donde se desempeñó en una serie de cargos de alto nivel en el área de finanzas, como tesorera asistente, gerenta general y gerenta de finanzas, GMAC Commercial Finance.  También cumplió una serie de labores en fusiones y adquisiciones, negociaciones laborales y tesorería.
"Estoy muy entusiasmada por ser parte de la transformación continua de Bausch + Lomb en su camino para hacer crecer el negocio y concretar su visión de convertirse en la mejor compañía global de salud ocular", señaló Hilado.
La señora Hilado es Licenciada en Ciencias con mención en ingeniería de administración de la Universidad Ateneo de Manila, Filipinas, y tiene un Master en Administración de Empresas de la Escuela de Negocios para Graduados Darden, de la Universidad de Virginia.  
Acerca de Bausch + Lomb Bausch + Lomb es una compañía global que trabaja en el ámbito de la salud ocular y, en particular, se dedica a proteger, mejorar y restablecer la vista de las personas.  Nuestras áreas de negocio clave son farmacéutica oftálmica, lentes de contacto y productos para cuidado de lentes, además de instrumentos y dispositivos para cirugía oftálmica.  A nivel global desarrollamos, fabricamos y comercializamos una de las carteras de productos más completas en nuestra industria, disponible en más de 100 países.  Fundada en 1853, nuestra matriz está en Rochester, NY, y damos empleo a más de 11.000 personas en todo el mundo.  
FUENTE  Bausch + Lomb
FUENTE  Bausch + Lomb
  SOURCE Bausch + Lomb  

RELATED LINKS
http://www.bausch.com



  

 View Table Fullscreen 




  View Table Fullscreen 



 

 
 



















































  











May 21, 2013, 10:00 ET
Preview: Bausch + Lomb Receives FDA Approval for the TRULIGN™ Toric Posterior Chamber Intraocular Lens


















May 15, 2013, 08:00 ET
Preview: Maria Teresa Hilado integra o Conselho Diretor da Bausch + Lomb








My News


  Release contains wide tables.	  View fullscreen.


















Search











Searching for your content...









Advanced Search









































 


 


Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft











Maria Teresa Hilado, Allergan PLC: Profile & Biography - Bloomberg


































































  





























Feedback





Maria Teresa "Tessa" Hilado

Exec VP/CFO,
Allergan PLC






Career History




Exec VP/CFO
Allergan PLC, 6/2015-PRESENT


Chief Financial Officer
Actavis PLC, 12/2014-6/2015


Senior VP:Finance/Treasurer
Pepsico Inc, 7/2009-12/2014


VP/Treasurer
Schering-Plough Corp/Pre-Merger With Merck & Co Inc, 5/2008-2009


Assistant Treasurer
General Motors Co, 2006-2008


Chief Financial Officer
Gmac Commercial Finance LLC/MI, 2001-2005



General Motors Co, 1990-UNKNOWN


Chief Financial Officer
Ally Financial Inc, FORMER



Far East Bank & Trust Co, FORMER


Show More









Website:
www.allergan.com






Corporate Information
Address:

Morris Corporate Center III
400 Interpace Parkway
Parsippany, NJ 07054
United States


Phone:
1-862-261-7000


Fax:
-


Web url:
www.allergan.com











From The Web












Personal Information



Education



Ateneo de Manila University
Bachelor's Degree


University of Virginia
MBA








Memberships



Board Memberships




Pepsi Bottling Ventures LLC


Board Member, PRESENT




HB Fuller Co


Board Member, 10/2013-PRESENT




Bausch & Lomb Inc


Board Member, 5/2013-8/2013



Show More








Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data







































	Newsroom


































































Text size
A-
A+














Contact Lenses
Contact Lens Care
Dry Eye Products
Allergy/Redness Relief
Rx Pharmaceutical
Eye Wash
Eye Vitamins
Surgical Products
Vision Accessories
Safety and Industrial Cleaning Products
Diagnostics






Lenses for Nearsighted/Farsighted
Bausch + Lomb ULTRA contact lenses
Biotrue ONEday Contact Lenses
PureVision2 Contact Lenses
PureVision Contact Lenses
SofLens daily disposable Contact Lenses
SofLens 38 Contact Lenses
Optima 38/SP Contact Lenses


Lenses for Astigmatism
Bausch + Lomb ULTRA for Astigmatism
Biotrue ONEday for Astigmatism
Soflens Daily Disposable Toric for Astigmatism Contact Lenses
PureVision2 for Astigmatism Contact Lenses
PureVision Toric Contact Lenses
SofLens Toric Contact Lenses
Optima Toric Contact Lenses


Lenses for Presbyopia
Bausch + Lomb ULTRA for Presbyopia
Biotrue ONEday for Presbyopia
PureVision2 for Presbyopia
PureVision Multi-Focal Contact Lenses
SofLens Multi-Focal Contact Lenses
Boston Multivision GP Contact Lenses


Lenses for Cataract Patients
Silsoft and Silsoft Super Contact Lenses


Vision Shaping Treatment
Rebate Center
Rewards Program




Soft Lens Multi-Purpose Solutions
Biotrue multi-purpose solution
renu Advanced Formula
PeroxiClear 3% Hydrogen Peroxide Cleaning & Disinfecting Solution
renu fresh multi-purpose solution
renu sensitive multi-purpose solution


Soft Contact Lens Drops
ReNu MultiPlus Lubricating and Rewetting Drops
ReNu Rewetting Drops
Sensitive Eyes Drops


Other Soft Lens Care Products
Sensitive Eyes Plus Saline
Sensitive Eyes Daily Cleaner


Gas Permeable Contact Lens Solutions
Boston Advance Conditioning Solution and Boston Advance Cleaner
Boston Simplus Multi-Action Solution
Boston Original Conditioning Solution and Cleaner
Peroxiclear Cleaning & Disinfecting Solution
Boston One Step Liquid Enzymatic
Boston Rewetting Drops for GP lenses
Boston Gas Permeable Lens Case


Specialty Lens Care Products
ScleralFil preservative free saline






Dry Eye Products
Soothe XP-Xtra Protection Emollient (Lubricant) Eye Drops
Soothe Long Lasting Hydration Lubricant Eye Drops
Soothe Hydration Lubricant Eye Drops
Soothe Preservative Free Lubricant Eye Drops
Soothe Night Time Ointment
THERA°PEARL Eye Mask
Advanced Eye Relief Dry Eye


Corneal Edema
Muro 128 Solution
Muro 128 Ointment






Alaway Antihistamine Eye Drops
Opcon-A Itching and Redness Reliever Eye Drops
Advanced Eye Relief Maximum Redness
Advanced Eye Relief Redness




Alrex (loteprednol etabonate ophthalmic suspension) 0.2%
BEPREVE (bepotastine besilate ophthalmic solution) 1.5%
Besivance (besifloxacin ophthalmic suspension) 0.6%
LACRISERT (hydroxypropyl cellulose ophthalmic insert)
Lotemax (loteprednol etabonate ophthalmic suspension 0.5%)
Lotemax (loteprednol etabonate ophthalmic-gel) 0.5%
Lotemax (loteprednol etabonate ophthalmic ointment) 0.5%
Istalol (timolol maleate ophthalmic solution) 0.5%
Macugen
PROLENSA (bromfenac ophthalmic solution)
Retisert (fluocinolone acetonide intravitreal implant)0.59 mg
TIMOPTIC 0.25% AND 0.5% (TIMOLOL MALEATE OPHTHALMIC SOLUTION) in OCUDOSE
Visudyne (verteporfin for injection) 15mg
Zirgan
Zylet Ophthalmic Suspension




Advanced Eye Relief Eye Wash
Collyrium for Fresh Eyes Eye Wash




Age Related Eye Vitamins
PreserVision Eye Vitamin AREDS 2
PreserVision Eye Vitamin AREDS Formula Soft Gels
PreserVision Lutein Formula Soft Gel
PreserVision AREDS Forumla Tablets
PreserVision AREDS 2 Formula + Multivitamin


Vitamins for Eye Health
Ocuvite Adult 50+ Formula
Ocuvite Lutein & Zeaxanthin Eye Vitamin
Ocuvite Lutein Eye Vitamin






Cataract Surgery
enVista IOL
Crystalens AO Lens
Trulign Toric IOL
Akreos AO Lens
SofPort Advanced Optics (AO) Aspheric Lens






Consumer Magnifiers
Magnifiers with ErgoTouch Grip
Bar Magnifiers
Illuminated Magnifiers
Illuminated Coddington


Professional Magnifiers
Coddington Magnifiers
Hastings Triplet Magnifiers
Classic Metal Eyeglass Loupes
Watchmaker's Loupes
Hastings Triplet Measuring Magnifiers
Lenscope Magnifiers
Magna-Visor
Folding Pocket Magnifiers
Double Lens Magnifier


Eyewear Accessories
Eyewear Accessories


Eyewear Cleaning Products
Eyewear Cleaning Products


Electronic Device Cleaning Products
Clens Travel Cleaning Kit
Home & Office Cleaning Kit






Disposable Lens Cleaning Stations
FogShield XP Lens Cleaning Station
Large Disposable Lens Cleaning Station
Plastic Disposable Lens Cleaning Station


Permanent Lens Cleaning Stations
Pre-Packed Metal Lens Cleaning Station


Liquid Cleaning Fluids
Liquid Cleaning Fluids


Tissue & Cloth Refills
Tissue & Cloth Refills


Pre Moistened Cleaning Tissues
FogShield XP® Pre-Moistened Lens Cleaning Tissues
Pre-Moistened Tissues
Pre-Moistened Tissues with Silicone
Pre-Moistened Respirator and Equipment Wipes
Peel and Reseal Pre-Moistened Lens Cleaning Tissues






Ocular Allergy Diagnostic System
Sjö Diagnostic Test














Infant Eyes
Child Eyes
Teenager Eyes
20s and 30s eyes
40s and 50s Eyes
60+ Eyes






Eye Development
Eye Exams
Eye Concerns
Eye Safety




Eye Development
Eye Exams
Eye Concerns
Eye Safety




Eye Exams
Maintaining Healthy Eyes
Eye Safety
Vision Correction
Teens and Contact Lenses
Parents Guide to Contact Lenses


Sports and Vision




Eye Exams
Healthy Eyes
Eye Safety
Vision Correction
Sports Vision




Eye Development
Eye Exams
Eye Concerns
Maintaining Healthy Eyes
Vision Correction




Eye Exams
Eye Concerns
Maintaining Healthy Eyes
Vision Correction














Vision Correction
Eye Infections & Irritations
Diseases and Disorders
Eye Injuries
Chronic Conditions
Wearing Contact Lenses






Nearsightedness (Myopia)
Farsightedness (Hyperopia)
Astigmatism
Presbyopia




Allergies
Computer Vision Syndrome (CVS)
Contact Lens Discomfort
Dry Eye
Eyelid Irritation
Pink Eye (conjunctivitis)
Foreign Objects / Eye Irritants
Infected Tear Duct
Sties
Watery Eyes
Tired Eyes




Age-Related Macular Degeneration
Bulging Eyes
Cataracts
Cataracts in Babies
Diabetic Macular Edema
CMV Retinitis
Color Blindness
Crossed Eyes (Strabismus)
Keratoconus
Eye Floaters and Eye Flashes
Glaucoma
Lazy Eye
Ocular Hypertension
Retinal Detachment
Low Vision
Eyelid Twitching
Uveitis




Chemical Eye Burns
Eye Trauma
Foreign Objects / Eye Irritants




Bell's Palsy
Diabetes
Graves’ Disease
Rheumatoid Arthritis
Sjogren’s Syndrome




Teens and Contact Lenses
Wearing and Caring for Contact Lenses














About Bausch + Lomb
Business Integrity
Compliance
Newsroom
Careers
Community Relationships
Grants and Charitable Contributions
Investor Relations
Supplier Diversity
Contract Manufacturing
Worldwide Locations
Contact Us
Formerly Owned Businesses






The Bausch + Lomb Story
Archive Request Form




Code of Business Conduct and Ethics
Corporate Governance Documents
Consumer Product Safety Improvement Act (CPSIA) Certificates


AdvaMed and PhRMA
Verified-Accredited Wholesale Distributor (VAWD)
California Transparency in Supply Chains Act of 2010




2016 Archive
2015 Archive
2014 archive
2013 archive
2012 archive
2011 archive
2010 archive
2009 archive
2008 archive
Media Contacts




Benefits
Retiree Benefits
Employee Benefits
Sustainability and Global Citizenship
Culture
Diversity
Internships




Social Investing
Environmental Sustainability
Science Award and Scholarships
FIRST - For Inspiration and Recognition of Science and Technology
Transfer of Flags Ceremony




Grants and Charitable Contributions Landing
Information and Requirements




Supplier Expectations
Diverse Certification Requirements
Commodities We Purchase
Second Tier Relationships
Diverse Supplier Profile
Contact Us




Contract Manufacturing
About Contract Manufacturing
Capabilities
Products
Contact Us for Contract Manufacturing Opportunities













Search























Search








Our Company  Newsroom






 



Newsroom















 



Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.






















7/17/2017, Monday



Bausch + Lomb Launches Innovative Contact Lens Patient Savings & Rewards Program














7/12/2017, Wednesday



Bausch + Lomb Launches FortifEYE™ Capsular Tension Ring Preloaded Single-use Injector Simplifies CTR Implantation














6/20/2017, Tuesday



Bausch + Lomb Unveils AMD Virtual Experience with State-of-the-Art Technology at Optometry’s Meeting














5/22/2017, Monday



Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution














5/10/2017, Wednesday



Bausch + Lomb Reports Updated Results of the Antibiotic Resistance Monitoring in Ocular MicRoorganisms (ARMOR) Study














5/3/2017, Wednesday



Bausch + Lomb Invites Surgeons to “Test Drive” New Next-Generation Phacoemulsification Platform at the American Society of Cataract and Refractive Surgery in Los Angeles














4/26/2017, Wednesday



Bausch + Lomb Receives 510(k) Clearance from FDA for Vitesse™, the Only Hypersonic, Open Port Vitrectomy System














4/17/2017, Monday



Bausch + Lomb ONE by ONE Recycling Program Reports Over 180,000 Units of Contact Lenses and Blister Packs Saved from Landfills Since Program Launch














4/6/2017, Thursday



Bausch + Lomb Receives 510(k) Clearance from FDA for Stellaris Elite™ Next-Generation Phacoemulsification Platform














3/30/2017



Introducing Bausch + Lomb ULTRA® for Astigmatism Contact Lenses














3/30/2017, Thursday



Bausch + Lomb Announces U.S. Management Team Leadership














3/1/2017, Wednesday



Bausch + Lomb Educates Over 200 Eye Care Professionals During B+Lieve™ Symposium in San Francisco, CA














3/1/2017, Wednesday



Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses














2/1/2017, Wednesday



Bausch + Lomb and Prevent Blindness® Urge Americans to Fight for Their Sight














1/26/2017, Thursday



Bausch + Lomb Specialty Vision Products Introduces ScleralFil™ Solution for Scleral Lens Insertion














1/18/2017, Wednesday



Bausch + Lomb Introduces Zen™ RC Scleral Contact Lenses














1/17/2017, Tuesday



Bausch + Lomb Successfully Defends Patent Covering PreserVision® Eye Vitamins in Case vs. Vitamin Health, Inc.














1/10/2017, Tuesday



Bausch + Lomb ULTRA® for Presbyopia Contact Lenses Parameters Expanded














12/21/2016, Wednesday



Bausch + Lomb Raises $40K+ for Optometry Giving Sight in Support of 2016 World Sight Day Challenge














12/12/2016, Monday



Bausch + Lomb Specialty Vision Products Launches New 28 Lens Zenlens™ Dx Set










Page 1 of 5First   Previous   [1]  2  3  4  5  Next   Last   













 News - Related Links 



Media Contacts
2017 Archives (18)
2016 Archives (30)
2015 Archives (25)
2014 Archives (24)
2013 Archives (36)
2012 Archives (29)
2011 Archives (39)
2010 Archives (67)
2009 Archives (56)
2008 Archives (32)
2007 Archives (44)























UNITED STATES





--Please Select--
Argentina
Australia
Österreich
Belgique
Brasil

Canada (English)
Canada (Français)
中国
Česká republika
Danmark
Eesti
Suomi
France
Deutschland
Greece
香港

India
Indonesia
Ireland
Italia
日本
한국
Latvia
Lietuva
Malaysia
México
Netherlands
New Zealand
Norge
Pakistan
Philippines
Polska
România
Россия
Singapore

South Africa
España
Sverige
Suisse
Schweiz
Taiwan
Türkiye

United Kingdom
United States





Vision and Eye Health

Vision and Age
Eye Infections & Irritations
Diseases and Disorders
Find a Doctor

Eye Exam Check List





Products

Contact Lenses
Contact Lens Care
Dry Eye Products
Allergy/Redness Relief
Rx Pharmaceutical
Eye Vitamins
Surgical Products
Vision Accessories





Customer Support

Contact Us
Customer policies and forms
Rebate Center
Worldwide Locations





Legal

Legal Notice
Privacy Policy
Safety Data Sheets (SDS)






Newsroom
Careers
Investor Relations
Grants & Contributions





© 2017 Bausch & Lomb Incorporated.
All information and materials on this site pertain to the U.S. only, unless otherwise indicated.






























	Actavis Names Maria Teresa Hilado Chief Financial Officer - Allergan

















































Home<HomeInvestors<InvestorsNews<NewsEvents & Presentations<Events & PresentationsInvestor FAQs<Investor FAQsAnalysts Coverage<Analysts CoverageStock Information<Stock InformationM&A Activities<M&A ActivitiesCorporate Governance<Corporate GovernanceShareholder Services<Shareholder ServicesFinancial Information<Financial InformationProducts<ProductsWhat We Treat<What We TreatKey Products<Key ProductsDrug Safety<Drug SafetyQuality<QualityPatent Notices<Patent NoticesMedical Information<Medical InformationR & D<R & DWe Live Open Science<We Live Open ScienceR&D Areas of Focus<R&D Areas of FocusAllergan Pipeline<Allergan PipelineClinical Trials<Clinical TrialsAbout<AboutCompany Profile<Company ProfileExecutive Leadership<Executive LeadershipGlobal Footprint<Global FootprintGlobal Locations<Global LocationsContact<ContactResponsibility<ResponsibilitySocial Contract<Social ContractSocial Responsibility<Social ResponsibilityAllergan Foundation<Allergan FoundationCalifornia Supply Chain Disclosure<California Supply Chain DisclosureAlliance Support and IME Grants<Alliance Support and IME GrantsHealth Care Provider Partnerships & Payments<Health Care Provider Partnerships & PaymentsPatient Resources<Patient ResourcesPatient Safety & Product Quality<Patient Safety & Product QualityPhysician Resources<Physician ResourcesAnimal Testing<Animal TestingNews<NewsPress Releases<Press ReleasesMedia Contacts<Media ContactsNewsroom<NewsroomCareers<CareersCareer Opportunities<Career OpportunitiesWorking at Allergan<Working at AllerganUniversity Recruiting<University RecruitingVeterans<Veterans















Home >



Investors >


Read the full story>
Allergan Acquisition: Investor Information


News

Events & Presentations

Investor FAQs

Analysts Coverage

Stock Information
Stock Chart & Quote
 Historical Price Lookup
 Investment Calculator

M&A Activities
Allergan Acquisition
 Forest Laboratories Acquisition
 Warner Chilcott Acquisition
 Teva Agreement

Corporate Governance
Executive Officers and Directors
 Committee Composition
 Committee Charters
 Code of Conduct
 Governance Guidelines
 Insider Transactions
 Allergan Compliance Program
 Memorandum of Association

Shareholder Services
Information Requests
 Investor Kit
 E-mail Alerts
 Dividends

Financial Information
SEC Filings
 Annual Reports
 Quarterly Results
 Proxy Materials
 Corporate Fact Sheet




Products >

What We Treat

Key Products
Our Products
 Product Prescribing

Drug Safety

Quality

Patent Notices

Medical Information
Medical Information Request




R & D >

We Live Open Science

R&D Areas of Focus

Allergan Pipeline

Clinical Trials
Participating in an Allergan Clinical Trial
 Clinical Trial results sharing
 Post Marketing Commitments
 Sharing Patient-Level Data
 Clinical Trials Investigators
 Investigator Initiated Trials




About >


LEARN MORE>
A global Growth Pharma leader


Company Profile

Executive Leadership

Global Footprint
Pharmaceuticals
 Business Development

Global Locations
Commercial Operations
 Supply Chain
 Countries

Contact




Responsibility >


LEARN MORE>
High priorities: sustainability & continual improvement


Social Contract

Social Responsibility
Environmental
 Employees
 Facilities & Manufacturing
 Partners
 Community
 Public Policy

Allergan Foundation

California Supply Chain Disclosure

Alliance Support and IME Grants
Alliance Support
 Independent Medical Education Grants

Patient Resources
Patient Assistance Programs

Patient Safety & Product Quality
Research and Development
 Risks and Benefits
 Quality

Physician Resources

Animal Testing




News >

CEO Blog

Press Releases

Media Contacts

Newsroom
Allergan Images
 Allergan Logos
 Company Profile
 Executive Bios & Photos




Careers >

Career Opportunities

Working at Allergan
Our Employees

University Recruiting
Internship & Co-ops
 Fellowship Programs

Veterans






>Go!










News > Press Releases







CEO Blog


Press Releases


Media Contacts


Newsroom











NEWS SEARCH


11.10.2014
        | 
      Investors
    
Actavis Names Maria Teresa Hilado Chief Financial Officer






- Expertise in global finance, M&A, business development -
- Will join Actavis effective December 8, 2014 -

DUBLIN, Nov. 10, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that Maria Teresa (Tessa) Hilado will join the Company, effective December 8, 2014, as Chief Financial Officer.  
Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO 
Ms. Hilado brings more than 26 years of global finance experience to the position, and will be based at the Company's Parsippany, NJ, U.S. Administrative Headquarters.  She will succeed R. Todd Joyce, who will remain with Actavis through early 2015 to support the transition.
"Tessa is an experienced, finance leader whose nearly three decades in financial leadership roles at some of the world's leading multinational corporations will be invaluable to Actavis as we continue our evolution as one of the fastest-growing and most dynamic pharmaceutical companies in the world," said Brent Saunders, Actavis CEO and President.  "She will bring extensive expertise in global finance, mergers and acquisitions and business development, and is widely recognized for her exceptional leadership skills. We are excited to add a senior executive of Tessa's caliber to Actavis."
Ms. Hilado joins Actavis from PepsiCo, Inc., where she has served as Senior Vice President, Finance and Treasurer since 2009.  Prior to PepsiCo, she served as Vice President and Treasurer for Schering-Plough Corporation from 2008 to 2009.  Ms. Hilado spent more than 17 years with General Motors Corporation, in a variety of increasingly responsible positions most notably Assistant Treasurer from 2006 to 2008, and previously CFO GMAC Commercial Finance LLC from 2001 to 2005.  She also held positions in the capital markets, business development, worldwide funding and pension analysis and overseas financing functions.  She began her career with Far East Bank and Trust Company, Manila, Philippines.
Ms. Hilado serves on the Board of Directors of H.B. Fuller, and previously served on the Board of Directors of Bausch & Lomb.  She earned a Master's in Business Administration from the University of Virginia's Darden School of Business Administration, and a Bachelor of Science in Management Engineering from Ateneo de Manila University in the Philippines. 
About Actavis
Actavis plc (NYSE:ACT), headquartered in Dublin, Ireland, is a unique specialty pharmaceutical company focused on developing, manufacturing and commercializing high quality affordable generic and innovative branded pharmaceutical products for patients around the world.  
Actavis markets a broad portfolio of branded and generic pharmaceuticals and develops innovative medicines for patients suffering from diseases principally in the central nervous system, gastroenterology, women's health, urology, cardiovascular, respiratory and anti-infective therapeutic categories.  The company is an industry leader in product research and development, with one of the broadest brand development pipelines in the pharmaceutical industry, and a leading position in the submission of generic product applications.  Actavis has commercial operations in more than 60 countries and operates more than 30 manufacturing and distribution facilities around the world.
For more information, visit Actavis' website at www.actavis.com.
Actavis Forward-Looking Statement
Statements contained in this communication that refer to Actavis' estimated or anticipated future results, including estimated synergies, or other non-historical facts are forward-looking statements that reflect Actavis' current perspective of existing trends and information as of the date of this communication. Actual results may differ materially from Actavis' current expectations depending upon a number of factors affecting Actavis' business. These factors include, among others, the timing and success of product launches; the difficulty of predicting the timing or outcome of product development efforts and regulatory agency approvals or actions, if any; market acceptance of and continued demand for Actavis' products; difficulties or delays in manufacturing; and such other risks and uncertainties detailed in Actavis' periodic public filings with the Securities and Exchange Commission, including but not limited to Actavis plc's Annual Report on Form 10-K for the year ended December 31, 2013, Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 and from time to time in Actavis' other investor communications. Except as expressly required by law, Actavis disclaims any intent or obligation to update or revise these forward-looking statements.




CONTACTS:


Actavis:





Investors:





Lisa DeFrancesco





(862) 261-7152









Media:





Charlie Mayr





(862) 261-8030









David Belian





(862) 261-8141




SOURCE  Actavis plc





Print this page
Share on Facebook
Share on Twitter
Share on Google+
Share on LinkedIn
View our RSS Feed












Media Contacts




Mark Marmur
Global Corporate Media Relations
 +1 (862) 261 7558
 mark.marmur@allergan.com


Fran DeSena
U.S. Product Media Relations
 +1 (201) 427-8762
 frances.desena@allergan.com


Janet Kettels
International Product Media Relations
 +44 773 850 6476
 kettels_janet@allergan.com

For local media contacts in other countries, please visit the relevant country website.
Investor relations:

Karina Calzadilla
Investor Relations
 +1 (862) 261 7488
 investorrelations@allergan.com











Country Websites



Global


Corporate Website




Africa

South Africa
Egypt





Americas

Argentina
Barbados
Bolivia
Brazil
Canada
Chile
Colombia
Costa Rica
Dominican Republic
Ecuador
El Salvador
Guatemala
Honduras
Jamaica
Mexico
Panama
Peru
Puerto Rico
Trinidad & Tobago
Uruguay
Venezuela



Asia Pacific

Australia
Bahrain
Bangladesh
China
Hong Kong
India
Indonesia
Israel
Japan
Jordan
Korea
Kuwait
Lebanon
Malaysia
New Zealand
Pakistan
Palestine
Philippines
Russia
Saudi Arabia


Sri Lanka
Singapore
Taiwan
Thailand
United Arab Emirates
Vietnam
Yemen






Europe

Austria
Belgium
Bulgaria
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lithuania


Malta
Netherlands
Norway
Poland
Portugal
Romania
Serbia
Slovakia
Spain
Sweden
Switzerland
Turkey
Ukraine
United Kingdom








































 



 Maria Teresa Hilado Joins Bausch + Lomb Board of Directors 

         










    











 






 











 









Maria Teresa Hilado Joins Bausch + Lomb Board of Directors

May 15, 2013, 08:00 ET
		  		  										
						 from   Bausch + Lomb 


		 English
	 


  Latin America  - español













 
















































 

 




















 


ROCHESTER, N.Y., May 15, 2013 /PRNewswire/ -- Bausch + Lomb, the global eye health company, today announced that Maria Teresa (Tessa) Hilado has been elected to its board of directors.
(Logo: http://photos.prnewswire.com/prnh/20121221/MM34011LOGO )
Ms. Hilado is currently senior vice president of finance and treasurer of PepsiCo, the $65 billion food and beverage giant.  In this capacity, Ms. Hilado has global operating responsibility for PepsiCo's treasury organization, which includes capital markets, cash management, international treasury, pension investments, and insurance, as well as oversight of the company's global procurement finance team.  She is also a member of PepsiCo's Capital Expenditures and Commodity Risk Management Committees, and chairs its Pension Investment Committee.  Ms. Hilado also sits on the board of Pepsi Bottling Ventures, a joint venture between PepsiCo and Suntory.
"Tessa Hilado is a brilliant finance leader with broad-based experience, in large global health care and consumer products companies," said Fred Hassan, chairman, Bausch + Lomb. "Bausch + Lomb, its customers and shareholders will benefit from Tessa's industry, finance and treasury experience."
Ms. Hilado has over 22 years of finance, treasury and strategic experience in large global public corporations across a variety of industries. Prior to joining PepsiCo in 2009, Hilado was vice president and treasurer at Schering-Plough Corporation from 2008 – 2009 where she had global operating responsibility for the company's treasury organization and served on the Pension Investment Committee.  Previously, Hilado spent 17 years at General Motors (GM) Corporation where she held a variety of senior finance roles including assistant treasurer, general manager and chief financial officer, GMAC Commercial Finance.  She also held a variety of positions in M&A, labor negotiations, and treasury.
"I am very excited to be part of Bausch + Lomb's continued transformation as they work to grow the business, and realize its vision of becoming the best global eye health company," said Hilado.
Ms. Hilado holds a Bachelor of Science in management engineering from Ateneo de Manila University, Philippines, and a Master of Business Administration from the University of Virginia, Darden Graduate School of Business.  
About Bausch + Lomb Bausch + Lomb is a leading global eye health company that is solely focused on protecting, enhancing, and restoring people's eyesight.  Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments.  We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries.  Founded in 1853, our company is headquartered in Rochester, NY, and employs more than 11,000 people worldwide.  
 SOURCE  Bausch + Lomb  

RELATED LINKS
http://www.bausch.com



  

 View Table Fullscreen 




  View Table Fullscreen 





Journalists and Bloggers
The news you need, when you need it.
 
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.
LEARN MORE




 

 
 



















































  
















May 15, 2013, 08:00 ET
Preview: Maria Teresa Hilado integra o Conselho Diretor da Bausch + Lomb




















May 09, 2013, 07:30 ET
Preview: Alex Kelly Joins Bausch + Lomb as Vice President Investor Relations








My News


  Release contains wide tables.	  View fullscreen.





Looking to send a news release with PR Newswire?
Take advantage of the world's leading distribution platform.
Sign up to get started
Request more information
Have an account? Log In

 















Search











Searching for your content...









Advanced Search












































 


  




















































This site is optimized for Chrome, Firefox and Safari. Internet Explorer users, please disable compatibility mode for best viewing experience.
        ×















North America
Latin America
Europe, India, Middle-East and Africa
Asia Pacific
  中文






























Focused On








																								Europe, India, Middle-East and Africa											



													News and Events				



													Newsroom				







Business News
Corporate News









																			View All News Releases
																		




Next 
	      							



H.B. Fuller Elects Maria Teresa Hilado to Board of Directors				
									August 19, 2013								
				
Experienced Executive to Strengthen Company's Execution of Profitable Growth Strategy
ST. PAUL, Minn., Aug. 19, 2013 - H.B. Fuller Company (NYSE: FUL) today announced that Maria Teresa (Tessa) Hilado was elected as an independent member to its board of directors, effective October 1, 2013. Hilado's position expands the board to nine directors, eight of whom are independent.   
Hilado is currently senior vice president, finance, and treasurer at PepsiCo. Inc. "I am pleased to welcome Tessa to the H.B. Fuller board of directors," said Lee Mitau, chairman, H.B. Fuller board of directors. "She brings deep knowledge and understanding of corporate finance and treasury, and as an experienced leader, she will enable us to achieve our goals and deliver long-term value to our shareholders."
Hilado's experience in finance, treasury and corporate strategy spans several large, global, public corporations in a variety of industries. Named to her current role in 2009, she has global operating responsibility for PepsiCo's treasury organization (capital markets, cash management, international treasury, pension investments and insurance)  and leads a number of global business initiatives. Before joining PepsiCo, she was vice president and treasurer at Schering Plough Corporation (now Merck). Prior to that, Hilado built a 17-year career at General Motors, where she moved to positions of increasing responsibility in mergers and acquisitions, labor negotiations and treasury. She also held a variety of senior finance roles, including assistant treasurer at GM and chief financial officer at GMAC Commercial Finance.
"Tessa is a strategic leader with demonstrated, global business acumen," said Jim Owens, H.B. Fuller president and chief executive officer. "Her keen understanding of corporate finance, coupled with her global experience and strategic insight, will greatly enhance our board. I am confident that Tessa will be a great asset as we continue to transform H.B. Fuller."
"H.B. Fuller's profitable growth strategy is gaining momentum," said Hilado. "I am pleased to be able to share my experience in finance and treasury to help the company achieve its strategic goals."
Hilado serves on the board of Pepsi Bottling Ventures and, until recently, served on the board of Bausch + Lomb. Last year, she was named by Treasury and Risk Magazine as one of the "100 Most Influential People in Finance." Hilado holds a BS in Management Engineering from Ateneo de Manila University (Philippines) and an MBA from the University of Virginia, Darden Graduate School of Business. She is a Co-chair of the 2013 Strong Kids Campaign of the YMCA of Greater New York.
About H.B. Fuller Company: For over 125 years, H.B. Fuller has been a leading global adhesives provider focusing on perfecting adhesives, sealants and other specialty chemical products to improve products and lives. Recognized for unmatched technical support and innovation, H.B. Fuller brings knowledge and expertise to help its customers find precisely the right formulation for the right performance. With fiscal 2012 net revenue of $1.9 billion, H.B. Fuller serves customers in packaging, hygiene, general assembly, electronic and assembly materials, paper converting, woodworking, construction, automotive and consumer businesses. For more information, visit us at www.hbfuller.com and subscribe to our blog.
###
Contacts:
Kimberlee Sinclair
Corporate Communications
+1 651 236 5823
kimberlee.sinclair@hbfuller.com
Maximillian Marcy
Investor Relations
+1 651 236 5062
max.marcy@hbfuller.com  
H.B. Fuller Company









 

				Knowledge
				Innovation
		     	Performance
		   	



Just Ask Us
Tell us your adhesives challenge or get product advice.

Contact a consultant



Contact Us About a Product

Request more information
Purchase products
Customer support

















Maria Teresa Hilado | Directors and Boards
























Skip to main content










Login
 Username *
 Password *


GO >
Forgot password?  Not a Subscriber? 

















Search form
Search











Toggle navigation






















 













Ms. Maria Teresa  HiladoPepsiCo Inc.Purchase, NYPrior to joining PepsiCo, where she has served in her present position since 2009, she was VP and treasurer at Schering Plough Corp. She spent 17 years in senior positions at General Motors Co., including assistant treasurer at GM and CFO at GMAC Commercial Finance. In 2012 she was named one of the "100 Most Influential People in Finance" by Treasury and Risk Magazine. Also is a director of Pepsi Bottling Ventures and Bausch+Lomb.2013 Third QuarterAdded to: H.B. Fuller Co. - St. Paul, MNH.B. Fuller markets adhesives, sealants, coatings, paints, and other specialty chemical products. Revenues are $2 billion.















 















 








